Sign in
4

Changes in Ownership

BIOMARIN PHARMACEUTICAL INC Filed Acc 0001628280-26-075143

EVP, Chief R&D Officer sold 5,147 shares at $58.81 ($302,711)

From the SEC's structured data for this filing

Trades in this filing

Friberg Gregory R · EVP, Chief R&D Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-11-18 Sale : show line 1 in the form −5,147 $58.81 $302,711 42,585 D
Open-market sales · 5,147 sh · avg $58.81 · $302,711
Loading xslF345X06/wk-form4_1795129447.xml…